• For Australian healthcare professionals only.

  • For Australian healthcare professionals only.

  • Contact a BMS representative

  • CAMZYOS Product Information

camzyos_logo
About Obstructive HCM
MOA
Clinical Trials
EXPLORER-HCM
Study Design
Efficacy Results
Safety
VALOR-HCM
Study Design
Efficacy Results
Safety
Dosing, Interactions & Precautions
Resources
My profile Log Out

Code Login
Doccheck
Code Login
Inami Login
Doccheck
Doccheck
Inami Login
Code Login
Inami Login
Failed
 
Error
Error
Success
Success

foot note heading

3500-AU-2400069. April 2024.

triangle

This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

Please refer to the approved CAMZYOS Product Information, Boxed Warning and Black Triangle before prescribing (Click HERE).

Please refer to the approved CAMZYOS Product Information, Boxed Warning and Black Triangle before prescribing (Click HERE).

bms logo

Contact Us

Privacy Policy

Terms of Use

Modern Slavery Statement

© 2025 Bristol-Myers Squibb. CAMZYOS® is a registered trademark of MyoKardia Inc, a Bristol-Myers Squibb Company. BMS Medical Information: 1800 067 567.
Bristol-Myers Squibb Australia Pty Ltd, ABN 33 004 333 322, 4 Nexus Court, Mulgrave, VIC 3170. BRMSCH2045.